Qsymia - 62541-201-30 - (phentermine hydrochloride and topiramate)

Alphabetical Index


Drug Information of Qsymia

Product NDC: 62541-201
Proprietary Name: Qsymia
Non Proprietary Name: phentermine hydrochloride and topiramate
Active Ingredient(s): 3.75; 23    mg/1; mg/1 & nbsp;   phentermine hydrochloride and topiramate
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Qsymia

Product NDC: 62541-201
Labeler Name: Vivus, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022580
Marketing Category: NDA
Start Marketing Date: 20120918

Package Information of Qsymia

Package NDC: 62541-201-30
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-201-30)

NDC Information of Qsymia

NDC Code 62541-201-30
Proprietary Name Qsymia
Package Description 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-201-30)
Product NDC 62541-201
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name phentermine hydrochloride and topiramate
Dosage Form Name CAPSULE, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20120918
Marketing Category Name NDA
Labeler Name Vivus, Inc.
Substance Name PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
Strength Number 3.75; 23
Strength Unit mg/1; mg/1
Pharmaceutical Classes Appetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC],Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]

Complete Information of Qsymia


General Information